Increased proliferation and angiogenesis by EGFR are thought to be caused by the binding ligands TGFα and EGF, which have shown to function as chemoattractants for endothelial cells and promote the expression of VEGF by tumor cells. The gene discussed is EGFR; the disease is neoplasm.